Skip to main content

Table 3 Site-Directed Mutants of novel NNRTI resistance associated mutations 139R, 219D and 219H in combination with 103N+181C and SDM 181G

From: Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutations

SDM

drug

3 measurements (Fold Changea)

139R

NVP

7.3

7.3

6.4

 

EFV

1.5

2.2

2.7

 

ETR

1.2

1.2

1.0

219D

NVP

3.7

3.8

1.4

 

EFV

1.3

2.2

1.3

 

ETR

1.1

2.0

0.4

219H

NVP

2.1

2.2

1.3

 

EFV

1.1

1.0

1.8

 

ETR

1.8

1.7

1.1

103N

NVP

> 51.7

> 54.2

35.4

 

EFV

19.5

15.1

12.5

 

ETR

1.1

0.9

0.6

103N+181C

NVP

> 85.9

> 85.9

> 85.9

 

EFV

28.4

23.1

38.7

 

ETR

4.2

1.7

3.2

139R+103N+181C

NVP

> 22.7

> 21.8

> 22.7

 

EFV

60.2

77.0

61.2

 

ETR

7.0

7.4

5.6

219D+103N+181C

NVP

> 79.6

> 79.6

> 76.7

 

EFV

116.6

72.9

48.6

 

ETR

15.5

20.2

21.4

219H+103N+181C

NVP

> 79.6

> 79.6

> 79.6

 

EFV

92.6

23.7

49.0

 

ETR

14.5

16.1

11.6

181G

NVP

30.1

38.3

> 37.2

 

EFV

1.6

1.3

1.1

 

ETR

1.5

0.9

1.2

  1. a > Biological Cut-Off (BCO) in bold, ≤ BCO in italic; BCO for NVP is 6.0, BCO for EFV is 3.3 and BCO for ETR is 3.2.